Widespread Fosfomycin Resistance in Gram-Negative Bacteria Attributable to the Chromosomal fosA Gene
- PMID: 28851843
- PMCID: PMC5574708
- DOI: 10.1128/mBio.00749-17
Widespread Fosfomycin Resistance in Gram-Negative Bacteria Attributable to the Chromosomal fosA Gene
Abstract
Fosfomycin is a decades-old antibiotic which is being revisited because of its perceived activity against many extensively drug-resistant Gram-negative pathogens. FosA proteins are Mn2+ and K+-dependent glutathione S-transferases which confer fosfomycin resistance in Gram-negative bacteria by conjugation of glutathione to the antibiotic. Plasmid-borne fosA variants have been reported in fosfomycin-resistant Escherichia coli strains. However, the prevalence and distribution of fosA in other Gram-negative bacteria are not known. We systematically surveyed the presence of fosA in Gram-negative bacteria in over 18,000 published genomes from 18 Gram-negative species and investigated their contribution to fosfomycin resistance. We show that FosA homologues are present in the majority of genomes in some species (e.g., Klebsiella spp., Enterobacter spp., Serratia marcescens, and Pseudomonas aeruginosa), whereas they are largely absent in others (e.g., E. coli, Acinetobacter baumannii, and Burkholderia cepacia). FosA proteins in different bacterial pathogens are highly divergent, but key amino acid residues in the active site are conserved. Chromosomal fosA genes conferred high-level fosfomycin resistance when expressed in E. coli, and deletion of chromosomal fosA in S. marcescens eliminated fosfomycin resistance. Our results indicate that FosA is encoded by clinically relevant Gram-negative species and contributes to intrinsic fosfomycin resistance.IMPORTANCE There is a critical need to identify alternate approaches to treat infections caused by extensively drug-resistant (XDR) Gram-negative bacteria. Fosfomycin is an old antibiotic which is routinely used for the treatment of urinary tract infections, although there is substantial interest in expanding its use to systemic infections caused by XDR Gram-negative bacteria. In this study, we show that fosA genes, which encode dimeric Mn2+- and K+-dependent glutathione S-transferase, are widely distributed in the genomes of Gram-negative bacteria-particularly those belonging to the family Enterobacteriaceae-and confer fosfomycin resistance. This finding suggests that chromosomally located fosA genes represent a vast reservoir of fosfomycin resistance determinants that may be transferred to E. coli Furthermore, they suggest that inhibition of FosA activity may provide a viable strategy to potentiate the activity of fosfomycin against XDR Gram-negative bacteria.
Keywords: Gram negative; fosfomycin resistance; genomics; glutathione S-transferase; phylogenetics.
Copyright © 2017 Ito et al.
Figures


Similar articles
-
Inhibition of Fosfomycin Resistance Protein FosA by Phosphonoformate (Foscarnet) in Multidrug-Resistant Gram-Negative Pathogens.Antimicrob Agents Chemother. 2017 Nov 22;61(12):e01424-17. doi: 10.1128/AAC.01424-17. Print 2017 Dec. Antimicrob Agents Chemother. 2017. PMID: 28993329 Free PMC article.
-
Structure and Dynamics of FosA-Mediated Fosfomycin Resistance in Klebsiella pneumoniae and Escherichia coli.Antimicrob Agents Chemother. 2017 Oct 24;61(11):e01572-17. doi: 10.1128/AAC.01572-17. Print 2017 Nov. Antimicrob Agents Chemother. 2017. PMID: 28874374 Free PMC article.
-
Glutathione-S-transferase FosA6 of Klebsiella pneumoniae origin conferring fosfomycin resistance in ESBL-producing Escherichia coli.J Antimicrob Chemother. 2016 Sep;71(9):2460-5. doi: 10.1093/jac/dkw177. Epub 2016 Jun 3. J Antimicrob Chemother. 2016. PMID: 27261267 Free PMC article.
-
Fosfomycin resistance mechanisms in Enterobacterales: an increasing threat.Front Cell Infect Microbiol. 2023 Jul 4;13:1178547. doi: 10.3389/fcimb.2023.1178547. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37469601 Free PMC article. Review.
-
An update on the management of urinary tract infections in the era of antimicrobial resistance.Postgrad Med. 2017 Mar;129(2):242-258. doi: 10.1080/00325481.2017.1246055. Epub 2016 Oct 21. Postgrad Med. 2017. PMID: 27712137 Review.
Cited by
-
Merging Metagenomics and Spatial Epidemiology To Understand the Distribution of Antimicrobial Resistance Genes from Enterobacteriaceae in Wild Owls.Appl Environ Microbiol. 2020 Oct 1;86(20):e00571-20. doi: 10.1128/AEM.00571-20. Print 2020 Oct 1. Appl Environ Microbiol. 2020. PMID: 32769191 Free PMC article.
-
#AMRrounds: a systematic educational approach for navigating bench to bedside antimicrobial resistance.JAC Antimicrob Resist. 2023 Aug 14;5(4):dlad097. doi: 10.1093/jacamr/dlad097. eCollection 2023 Aug. JAC Antimicrob Resist. 2023. PMID: 37583473 Free PMC article. Review.
-
Fosfomycin susceptibility of uropathogens at Charlotte Maxeke Johannesburg Academic Hospital.S Afr J Infect Dis. 2020 Oct 26;35(1):173. doi: 10.4102/sajid.v35i1.173. eCollection 2020. S Afr J Infect Dis. 2020. PMID: 34485478 Free PMC article.
-
Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial Resistance.Antimicrob Agents Chemother. 2021 Jun 17;65(7):e0029321. doi: 10.1128/AAC.00293-21. Epub 2021 Jun 17. Antimicrob Agents Chemother. 2021. PMID: 33972238 Free PMC article.
-
Enterobacterales use capsules, transporters, mobile genetic elements, and other evolutionary adaptations to survive antibiotics exposure in the absence of resistance genes.Virulence. 2025 Dec;16(1):2514092. doi: 10.1080/21505594.2025.2514092. Epub 2025 Jun 6. Virulence. 2025. PMID: 40474678 Free PMC article.
References
-
- Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, Soper DE; Infectious Diseases Society of America, European Society for Microbiology and Infectious Diseases . 2011. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52:e103–e120. doi:10.1093/cid/ciq257. - DOI - PubMed
-
- Endimiani A, Patel G, Hujer KM, Swaminathan M, Perez F, Rice LB, Jacobs MR, Bonomo RA. 2010. In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin. Antimicrob Agents Chemother 54:526–529. doi:10.1128/AAC.01235-09. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous